1.2020 Korean guidelines for the management of metastatic prostate cancer
In-Ho KIM ; Sang Joon SHIN ; Byung Woog KANG ; Jihoon KANG ; Dalyong KIM ; Miso KIM ; Jin Young KIM ; Chan Kyu KIM ; Hee-Jun KIM ; Chi Hoon MAENG ; Kwonoh PARK ; Inkeun PARK ; Woo Kyun BAE ; Byeong Seok SOHN ; Min-Young LEE ; Jae Lyun LEE ; Junglim LEE ; Seung Taek LIM ; Joo Han LIM ; Hyun CHANG ; Joo Young JUNG ; Yoon Ji CHOI ; Young Seok KIM ; Jaeho CHO ; Jae Young JOUNG ; Se Hoon PARK ; Hyo Jin LEE
The Korean Journal of Internal Medicine 2021;36(3):491-514
In 2017, Korean Society of Medical Oncology (KSMO) published the Korean management guideline of metastatic prostate cancer. This paper is the 2nd edition of the Korean management guideline of metastatic prostate cancer. We updated recent many changes of management in metastatic prostate cancer in this 2nd edition guideline. The present guideline consists of the three categories: management of metastatic hormone sensitive prostate cancer; management of metastatic castration resistant prostate cancer; and clinical consideration for treating patients with metastatic prostate cancer. In category 1 and 2, levels of evidence (LEs) have been mentioned according to the general principles of evidence-based medicine. And grades of recommendation (GR) was taken into account the quality of evidence, the balance between desirable and undesirable effects, the values and preferences, and the use of resources and GR were divided into strong recommendations (SR) and weak recommendations (WR). A total of 16 key questions are selected. And we proposed recommendations and described key evidence for each recommendation. The treatment landscape of metastatic prostate cancer is changing very rapid and many trials are ongoing. To verify the results of the future trials is necessary and should be applied to the treatment for metastatic prostate cancer patients in the clinical practice. Especially, many prostate cancer patients are old age, have multiple underlying medical comorbidities, clinicians should be aware of the significance of medical management as well as clinical efficacy of systemic treatment.
2.A study on research trends for gestational diabetes mellitus and breastfeeding: Focusing on text network analysis and topic modeling
Junglim LEE ; Youngji KIM ; Eunju KWAK ; Seungmi PARK
Journal of Korean Academic Society of Nursing Education 2021;27(2):175-185
Purpose:
The aim of this study was to identify core keywords and topic groups in the ‘Gestational diabetes mellitus (GDM) and Breastfeeding’ field of research for better understanding research trends in the past 20 years.
Methods:
This was a text-mining and topic modeling study composed of four steps: 1) collecting abstracts, 2) extracting and cleaning semantic morphemes, 3) building a co-occurrence matrix, and 4) analyzing network features and clustering topic groups.
Results:
A total of 635 papers published between 2001 and 2020 were found in databases (Web of Science, CINAHL, RISS, DBPIA, RISS, KISS). Among them, 3,639 words extracted from 366 articles selected according to the conditions were analyzed by text network analysis and topic modeling. The most important keywords were 'exposure', ‘fetus’, ‘hypoglycemia’, 'prevention' and 'program'. Six topic groups were identified through topic modeling. The main topics of the study were ‘cardiovascular disease' and 'obesity'. Through the topic modeling analysis, six themes were derived: ‘cardiovascular disease’, ‘obesity’, ‘complication prevention strategy’, ‘support of breastfeeding’, ‘educational program’ and ‘management of GDM’.
Conclusion
This study showed that over the past 20 years many studies have been conducted on complications such as cardiovascular diseases and obesity related to gestational diabetes and breastfeeding. In order to prevent complications of gestational diabetes and promote breastfeeding, various nursing interventions, including gestational diabetes management and educational programs for GDM pregnancies, should be developed in nursing fields.
3.2020 Korean guidelines for the management of metastatic prostate cancer
In-Ho KIM ; Sang Joon SHIN ; Byung Woog KANG ; Jihoon KANG ; Dalyong KIM ; Miso KIM ; Jin Young KIM ; Chan Kyu KIM ; Hee-Jun KIM ; Chi Hoon MAENG ; Kwonoh PARK ; Inkeun PARK ; Woo Kyun BAE ; Byeong Seok SOHN ; Min-Young LEE ; Jae Lyun LEE ; Junglim LEE ; Seung Taek LIM ; Joo Han LIM ; Hyun CHANG ; Joo Young JUNG ; Yoon Ji CHOI ; Young Seok KIM ; Jaeho CHO ; Jae Young JOUNG ; Se Hoon PARK ; Hyo Jin LEE
The Korean Journal of Internal Medicine 2021;36(3):491-514
In 2017, Korean Society of Medical Oncology (KSMO) published the Korean management guideline of metastatic prostate cancer. This paper is the 2nd edition of the Korean management guideline of metastatic prostate cancer. We updated recent many changes of management in metastatic prostate cancer in this 2nd edition guideline. The present guideline consists of the three categories: management of metastatic hormone sensitive prostate cancer; management of metastatic castration resistant prostate cancer; and clinical consideration for treating patients with metastatic prostate cancer. In category 1 and 2, levels of evidence (LEs) have been mentioned according to the general principles of evidence-based medicine. And grades of recommendation (GR) was taken into account the quality of evidence, the balance between desirable and undesirable effects, the values and preferences, and the use of resources and GR were divided into strong recommendations (SR) and weak recommendations (WR). A total of 16 key questions are selected. And we proposed recommendations and described key evidence for each recommendation. The treatment landscape of metastatic prostate cancer is changing very rapid and many trials are ongoing. To verify the results of the future trials is necessary and should be applied to the treatment for metastatic prostate cancer patients in the clinical practice. Especially, many prostate cancer patients are old age, have multiple underlying medical comorbidities, clinicians should be aware of the significance of medical management as well as clinical efficacy of systemic treatment.
4.A study on research trends for gestational diabetes mellitus and breastfeeding: Focusing on text network analysis and topic modeling
Junglim LEE ; Youngji KIM ; Eunju KWAK ; Seungmi PARK
Journal of Korean Academic Society of Nursing Education 2021;27(2):175-185
Purpose:
The aim of this study was to identify core keywords and topic groups in the ‘Gestational diabetes mellitus (GDM) and Breastfeeding’ field of research for better understanding research trends in the past 20 years.
Methods:
This was a text-mining and topic modeling study composed of four steps: 1) collecting abstracts, 2) extracting and cleaning semantic morphemes, 3) building a co-occurrence matrix, and 4) analyzing network features and clustering topic groups.
Results:
A total of 635 papers published between 2001 and 2020 were found in databases (Web of Science, CINAHL, RISS, DBPIA, RISS, KISS). Among them, 3,639 words extracted from 366 articles selected according to the conditions were analyzed by text network analysis and topic modeling. The most important keywords were 'exposure', ‘fetus’, ‘hypoglycemia’, 'prevention' and 'program'. Six topic groups were identified through topic modeling. The main topics of the study were ‘cardiovascular disease' and 'obesity'. Through the topic modeling analysis, six themes were derived: ‘cardiovascular disease’, ‘obesity’, ‘complication prevention strategy’, ‘support of breastfeeding’, ‘educational program’ and ‘management of GDM’.
Conclusion
This study showed that over the past 20 years many studies have been conducted on complications such as cardiovascular diseases and obesity related to gestational diabetes and breastfeeding. In order to prevent complications of gestational diabetes and promote breastfeeding, various nursing interventions, including gestational diabetes management and educational programs for GDM pregnancies, should be developed in nursing fields.
5.Erratum: Correction of the Text in the Article “Table”: Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study
Min Sun KIM ; Jihye LEE ; Jin Ah SIM ; Jung Hye KWON ; Eun Joo KANG ; Yu Jung KIM ; Junglim LEE ; Eun Kee SONG ; Jung Hun KANG ; Eun Mi NAM ; Si Young KIM ; Hwan Jung YUN ; Kyung Hae JUNG ; June Dong PARK ; Young Ho YUN
Journal of Korean Medical Science 2020;35(6):74-
While recently extending that research, however, the authors discovered that 236 members of the general population were mistakenly to be duplicated by the investigating agency (Word Research) and 1,241 were reported rather than 1,005. The authors present corrections and discuss the relevant data. The authors wish to apologize to the publisher and readers of Journal of Korean Medical Science for these errors.
6.Erratum: Correction of the Text in the Article “Tableâ€: Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study
Min Sun KIM ; Jihye LEE ; Jin Ah SIM ; Jung Hye KWON ; Eun Joo KANG ; Yu Jung KIM ; Junglim LEE ; Eun Kee SONG ; Jung Hun KANG ; Eun Mi NAM ; Si Young KIM ; Hwan Jung YUN ; Kyung Hae JUNG ; June Dong PARK ; Young Ho YUN
Journal of Korean Medical Science 2020;35(6):e74-
While recently extending that research, however, the authors discovered that 236 members of the general population were mistakenly to be duplicated by the investigating agency (Word Research) and 1,241 were reported rather than 1,005. The authors present corrections and discuss the relevant data. The authors wish to apologize to the publisher and readers of Journal of Korean Medical Science for these errors.
7.Erratum: Correction of Ethics Statement: Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study.
Min Sun KIM ; Jihye LEE ; Jin Ah SIM ; Jung Hye KWON ; Eun Joo KANG ; Yu Jung KIM ; Junglim LEE ; Eun Kee SONG ; Jung Hun KANG ; Eun Mi NAM ; Si Young KIM ; Hwan Jung YUN ; Kyung Hae JUNG ; June Dong PARK ; Young Ho YUN
Journal of Korean Medical Science 2019;34(3):e30-
The approval number of Institutional Review Board (IRB) was wrong in the article.
8.Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study.
Min Sun KIM ; Jihye LEE ; Jin Ah SIM ; Jung Hye KWON ; Eun Joo KANG ; Yu Jung KIM ; Junglim LEE ; Eun Kee SONG ; Jung Hun KANG ; Eun Mi NAM ; Si Young KIM ; Hwan Jung YUN ; Kyung Hae JUNG ; June Dong PARK ; Young Ho YUN
Journal of Korean Medical Science 2018;33(49):e327-
BACKGROUND: It is difficult to decide whether to inform the child of the incurable illness. We investigated attitudes of the general population and physicians toward prognosis disclosure to children and associated factors in Korea. METHODS: Physicians working in one of 13 university hospitals or the National Cancer Center and members of the general public responded to the questionnaire. The questionnaire consisted of the age appropriate for informing children about the prognosis and the reason why children should not be informed. This survey was conducted as part of research to identify perceptions of physicians and general public on the end-of-life care in Korea. RESULTS: A total of 928 physicians and 1,241 members of the general public in Korea completed the questionnaire. Whereas 92.7% of physicians said that children should be informed of their incurable illness, only 50.7% of the general population agreed. Physicians were also more likely to think that younger children should know about their poor prognosis compared with the general population. Physicians who opposed incurable illness disclosure suggested that children might not understand the situation, whereas the general public was primarily concerned that disclosure would exacerbate the disease. Physicians who were women or religious were more likely to want to inform children of their poor prognosis. In the general population, gender, education, comorbidity, and caregiver experience were related to attitude toward poor prognosis disclosure to children. CONCLUSION: Our findings indicate that physicians and the general public in Korea differ in their perceptions about informing children of poor prognosis.
Caregivers
;
Child*
;
Comorbidity
;
Disclosure*
;
Education
;
Female
;
Hospitals, University
;
Humans
;
Korea
;
Prognosis
;
Republic of Korea
9.Korean Treatment Guidelines for Metastatic Prostate Cancer Developed by the Korean Association for Clinical Oncology.
Inkeun PARK ; Byung Woog KANG ; Su Jin KOH ; Kyoung Ha KIM ; Se Hyun KIM ; Chan Kyu KIM ; Ho Young KIM ; Kwonoh PARK ; Se Hoon PARK ; Sung Yong OH ; Junglim LEE ; Hyo Jin LEE ; Seung Taek LIM ; Jae Cheol JO ; Jae Lyun LEE
Korean Journal of Medicine 2017;92(2):124-141
The management of advanced prostate cancer has evolved rapidly. Androgen deprivation therapy, via surgical or medical castration, is the first-line therapy for hormone-naïve metastatic prostate cancer. For approximately a decade, docetaxel-based chemotherapy was the only approved agent to show a survival benefit for castration-resistant prostate cancer. However, over the last 5 years, significant advances in the field have led to the approval of several new agents with different mechanisms of action, such as the new androgen pathway inhibitors abiraterone and enzalutamide, a new cytotoxic agent, cabazitaxel, and new bone-seeking agents such as radium-223, which have all been associated with improved quality of life and pain palliation and an increase in survival. However, there has been no Korean treatment guideline for metastatic prostate cancer which is developed based on thorough search for relevant articles, including recently developed agents, and adequate review and assessment of evidences, and thus, a guideline adequate for domestic circumstance is eagerly needed. Experts from the Genitourinary Oncology Committee of the Korea Cancer Study Group developed clinical recommendations for the treatment of metastatic prostate cancer based on 19 key questions. The Korean Association for Clinical Oncology, the Korean Prostate Society, the Korean Urological Oncology Society, and the Korean Society of Pathologists reviewed and endorsed the guidelines. These are the first Korean treatment guidelines developed specifically for metastatic prostate cancer.
Castration
;
Drug Therapy
;
Korea
;
Medical Oncology*
;
Neoplasm Metastasis
;
Prostate*
;
Prostatic Neoplasms*
;
Quality of Life
10.Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation.
Hong Ghi LEE ; Sung Yong KIM ; Inho KIM ; Yeo Kyeoung KIM ; Jeong A KIM ; Yang Soo KIM ; Ho Sup LEE ; Jinny PARK ; Seok Jin KIM ; Hyeok SHIM ; Hyeon Seok EOM ; Byeong Bae PARK ; Junglim LEE ; Sung Kyu PARK ; June Won CHEONG ; Keon Woo PARK
Blood Research 2015;50(3):160-166
BACKGROUND: Among the currently available prognostic models for diffuse large B-cell lymphoma (DLBCL), we investigated to determine which is most adoptable for DLBCL patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) followed by upfront autologous stem cell transplantation (auto-SCT). METHODS: We retrospectively evaluated survival differences among risk groups based on the International Prognostic Index (IPI), the age-adjusted IPI (aaIPI), the revised IPI (R-IPI), and the National Comprehensive Cancer Network IPI (NCCN-IPI) at diagnosis in 63 CD20-positive DLBCL patients treated with R-CHOP followed by upfront auto-SCT. RESULTS: At the time of auto-SCT, 74.6% and 25.4% of patients had achieved complete remission and partial remission after R-CHOP, respectively. As a whole, the 5-year overall (OS) and progression-free survival (PFS) rates were 78.8% and 74.2%, respectively. The 5-year OS and PFS rates according to the IPI, aaIPI, R-IPI, and NCCN-IPI did not significantly differ among the risk groups for each prognostic model (P-values for OS: 0.255, 0.337, 0.881, and 0.803, respectively; P-values for PFS: 0.177, 0.904, 0.295, and 0.609, respectively). CONCLUSION: There was no ideal prognostic model among those currently available for CD20-positive DLBCL patients treated with R-CHOP followed by upfront auto-SCT.
Autografts*
;
B-Lymphocytes*
;
Cyclophosphamide
;
Diagnosis
;
Disease-Free Survival
;
Doxorubicin
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Lymphoma, B-Cell*
;
Prednisone
;
Retrospective Studies
;
Stem Cell Transplantation
;
Transplantation, Autologous*
;
Vincristine
;
Rituximab

Result Analysis
Print
Save
E-mail